I stumbled upon a fascinating journal article while I was doing some research for the post I ran about John yesterday. Although I had seen the acronym, VDR-PACE, I wasn't familiar with the PACE part (continuous infusions of cis-platin, doxorubicin, cyclophosphamide, etoposide) of John's VDR-PACE inpatient induction regimen. It seems that VDR (Velcade, dexamethasone and
A reader requested a link to another of Dr. Stewart's recent studies about treating younger multiple myeloma patients. Here is the link: Blood - December 24, 2009. Worth a look. My only question? What is "younger" for multiple myeloma patients? The youngest I know is 22. But in multiple myeloma time, aren't I considered "young"